Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,336 | 804 | 87.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,625 | 1 | 12.5% |
| Education | $35.34 | 5 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,576 | 70 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,650 | 83 | $0 (2024) |
| Novo Nordisk Inc | $1,344 | 118 | $0 (2024) |
| Amgen Inc. | $761.54 | 35 | $0 (2024) |
| PFIZER INC. | $758.18 | 54 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $580.88 | 87 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $534.60 | 33 | $0 (2024) |
| GlaxoSmithKline, LLC. | $418.54 | 38 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $401.75 | 13 | $0 (2019) |
| Lilly USA, LLC | $367.80 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,505 | 104 | AstraZeneca Pharmaceuticals LP ($345.11) |
| 2023 | $1,821 | 111 | AstraZeneca Pharmaceuticals LP ($350.36) |
| 2022 | $3,272 | 102 | ABBVIE INC. ($1,896) |
| 2020 | $378.33 | 25 | AstraZeneca Pharmaceuticals LP ($50.24) |
| 2019 | $2,038 | 143 | AstraZeneca Pharmaceuticals LP ($269.02) |
| 2018 | $1,750 | 142 | Novo Nordisk Inc ($201.65) |
| 2017 | $2,232 | 183 | AstraZeneca Pharmaceuticals LP ($284.98) |
All Payment Transactions
810 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: PAIN | ||||||
| 12/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $5.44 | General |
| Category: PSYCHIATRY | ||||||
| 12/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $6.68 | General |
| Category: Obesity | ||||||
| 12/06/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: PSYCHIATRY | ||||||
| 12/06/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/22/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/20/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $4.02 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Cardio-renal | ||||||
| 11/11/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Neuropsychiatry | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $7.56 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: PAIN | ||||||
| 11/01/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: Endocrinology | ||||||
| 10/29/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: PSYCHIATRY | ||||||
| 10/24/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $8.42 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/17/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $14.73 | General |
| 10/15/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $2.38 | General |
| Category: Diabetes | ||||||
| 10/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: PSYCHIATRY | ||||||
| 10/11/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $13.71 | General |
| 10/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 968 | 1,489 | $351,058 | $113,937 |
| 2022 | 20 | 1,089 | 1,675 | $385,668 | $121,693 |
| 2021 | 27 | 1,749 | 2,372 | $329,004 | $124,014 |
| 2020 | 34 | 2,447 | 3,322 | $304,268 | $132,867 |
All Medicare Procedures & Services
98 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 226 | 482 | $140,744 | $35,288 | 25.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 200 | 200 | $59,600 | $22,592 | 37.9% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 85 | 264 | $52,800 | $19,565 | 37.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 118 | 167 | $34,402 | $9,355 | 27.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 29 | 29 | $13,050 | $7,775 | 59.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 61 | 95 | $19,665 | $4,959 | 25.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 58 | 58 | $7,076 | $4,172 | 59.0% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 15 | 17 | $7,939 | $2,441 | 30.7% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 23 | 23 | $3,565 | $2,167 | 60.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 13 | 13 | $4,888 | $1,897 | 38.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 66 | 66 | $3,300 | $1,890 | 57.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 30 | 30 | $1,500 | $858.90 | 57.3% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 12 | 12 | $1,572 | $672.32 | 42.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 21 | 22 | $550.00 | $199.92 | 36.3% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 11 | 11 | $407.00 | $104.68 | 25.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 246 | 575 | $167,900 | $42,532 | 25.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 187 | 187 | $55,726 | $22,132 | 39.7% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 83 | 200 | $39,894 | $12,916 | 32.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 106 | 148 | $30,488 | $8,206 | 26.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 23 | 23 | $10,350 | $6,086 | 58.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 67 | 95 | $19,562 | $5,556 | 28.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 64 | 64 | $7,808 | $4,315 | 55.3% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Facility | 2022 | 33 | 43 | $12,771 | $4,124 | 32.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 24 | 24 | $9,024 | $3,481 | 38.6% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 17 | 18 | $8,406 | $2,705 | 32.2% |
About Dr. Techsin Ty, MD
Dr. Techsin Ty, MD is a Internal Medicine healthcare provider based in Kokomo, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1992705156.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Techsin Ty, MD has received a total of $12,997 in payments from pharmaceutical and medical device companies, with $1,505 received in 2024. These payments were reported across 810 transactions from 58 companies. The most common payment nature is "Food and Beverage" ($11,336).
As a Medicare-enrolled provider, Ty has provided services to 6,253 Medicare beneficiaries, totaling 8,858 services with total Medicare billing of $492,511. Data is available for 4 years (2020–2023), covering 98 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Kokomo, IN
- Active Since 07/28/2005
- Last Updated 01/15/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1992705156
Products in Payments
- UBRELVY (Drug) $1,819
- FARXIGA (Drug) $1,305
- ACTHAR (Biological) $401.75
- ENTRESTO (Drug) $400.62
- INVOKANA (Drug) $400.42
- Enbrel (Biological) $346.28
- VRAYLAR (Drug) $333.90
- REXULTI (Drug) $308.78
- Saxenda (Drug) $286.41
- Kerendia (Drug) $282.28
- Wegovy (Drug) $245.95
- Ozempic (Drug) $238.59
- ELIQUIS (Drug) $209.93
- Humira (Biological) $198.88
- Victoza (Drug) $192.39
- Otezla (Drug) $183.94
- LINZESS (Drug) $179.00
- XARELTO (Drug) $174.44
- CHANTIX (Drug) $174.42
- NURTEC ODT (Drug) $154.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Kokomo
Mr. Lance Washington, Md, MD
Internal Medicine — Payments: $60,198
Fadi Hayek, Md, MD
Internal Medicine — Payments: $36,391
Gerald Greer, Md, MD
Internal Medicine — Payments: $10,978
Baikadi Ravindra, Md, MD
Internal Medicine — Payments: $10,828
Dr. Kelly Carlson, Md, MD
Internal Medicine — Payments: $7,470
Mrs. Dustardie Reed, Md, MD
Internal Medicine — Payments: $5,147